We make them accessible.
It’s also the science.
December 8, 2021 | BENZINGA Medical cannabis producer Panaxia Labs Israel Ltd. (TASE: PNAX), a subsidiary of Panaxia Global (TASE: PNAX) and Neuraxpharm, a European company that specializes in the central nervous system have launched sales
November 29, 2021 | Yahoo! The company resumed double-digit growth following a decrease in Q2 due to divesting its distribution and logistics operations. Revenues in the
From vision to reality: Panaxia and Neuraxpharm are the world’s first companies to sell medical cannabis extracts for inhalation in Europe
November 3, 2021 | Yahoo! This week, the first export of medical cannabis extracts for inhalation left Israel to Germany, the largest and fastest-growing medical cannabis
Panaxia continues growth: sums up 1st half of 2021 with 37.3 million revenues, 38.4% growth in comparison to 2020
September 2, 2021 | Yahoo! In the cumulative first six months of 2021, the company executed retail sales in Germany and Cyprus; Revenues of the 2nd
August 19, 2021 | Yahoo! The companies signed an agreement for the distribution of advanced medical cannabis-based products in Poland. First sales are expected during H1
July 29, 2021 | MarketWatch TEL AVIV, Israel and BIELEFELD, Germany, July 29, 2021 /PRNewswire via COMTEX/ — TEL AVIV, Israel and BIELEFELD, Germany, July 29,